MicroVision, Inc. (MVIS) financial statements: income statement, balance sheet and cash flow
MicroVision, Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), MicroVision, Inc. reported revenue of $1.2M (-74.3% year on year) and net income of ($95.1M) (+1.4% year on year).
Income statement
MicroVision, Inc. income statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Revenue
$1.2M
$4.7M
$7.3M
—
Cost of Revenue
$18.5M
$7.5M
$2.8M
$100.0K
Gross (loss) profit
($17.3M)
($2.8M)
$4.5M
$564.0K
Research and Development Expense
$31.7M
$49.0M
$56.7M
$30.4M
Selling, General and Administrative Expense
$20.3M
$29.3M
$36.7M
$24.0M
Impairment charge on intangible assets
$10.1M
$4.2M
—
—
Impairment loss on operating lease right-of-use assets
$1.2M
—
—
—
Impairment loss on property and equipment, net
$2.2M
—
—
—
Total operating expenses
$65.5M
$82.7M
$93.4M
$54.5M
Loss from operations
($82.8M)
($85.5M)
($88.9M)
($53.9M)
Interest expense
($18.5M)
($4.5M)
—
—
Non-Operating Income (Expense)
$5.7M
($8.9M)
$1.7M
—
Unrealized gain on warrant liability
$4.4M
—
—
—
Interest Expense
($4.7M)
—
—
$0
Non-Operating Income (Expense)
$817.0K
$2.4M
$5.5M
—
Net loss before taxes
($95.1M)
($96.4M)
($81.7M)
—
Income tax benefit (expense)
$84.0K
($507.0K)
($1.1M)
—
Net loss
($95.0M)
($96.9M)
($82.8M)
($53.1M)
Earnings Per Share (Basic)
-$0.35
-$0.46
-$0.45
-$0.32
Earnings Per Share (Diluted)
-$0.35
-$0.46
-$0.45
-$0.32
Weighted Average Shares Outstanding
273.1M
209.5M
182.8M
166.0K
Weighted Average Shares Outstanding, Diluted
273.1M
209.5M
182.8M
166.0K
MicroVision, Inc. income statement, quarters
Line item
Jun 30, 2026 · Q2
Mar 31, 2026 · Q1
Sep 30, 2025 · Q3
Jun 30, 2025 · Q2
Revenue
$1.5M
$935.0K
$241.0K
$155.0K
Cost of Revenue
$831.0K
$572.0K
$957.0K
$716.0K
Gross profit (loss)
$642.0K
$363.0K
($716.0K)
($561.0K)
Research and Development Expense
$15.7M
$14.4M
$8.0M
$7.7M
Selling, General and Administrative Expense
$9.2M
$9.5M
$4.0M
$6.4M
Gain on disposal of fixed assets
($60.0K)
($108.0K)
—
—
Total operating expenses
$24.9M
$23.9M
$12.0M
$14.1M
Loss from operations
($24.2M)
($23.5M)
($12.7M)
($14.7M)
Interest expense
($5.5M)
($2.8M)
($2.2M)
($2.2M)
Non-Operating Income (Expense)
($8.0M)
$3.4M
$1.1M
$2.0M
Unrealized gain on warrant liability
$891.0K
$604.0K
($326.0K)
$803.0K
Non-Operating Income (Expense)
$73.0K
$147.0K
$140.0K
($65.0K)
Net loss before taxes
($36.8M)
($25.1M)
($14.0M)
($14.1M)
Income tax expense
($181.0K)
($182.0K)
($172.0K)
($93.0K)
Net loss
($36.9M)
($25.3M)
($14.2M)
($14.2M)
Earnings Per Share (Basic)
-$1.66
-$0.08
-$0.05
-$0.06
Earnings Per Share (Diluted)
-$1.66
-$0.08
-$0.05
-$0.06
Weighted Average Shares Outstanding
22.3M
308.6M
295.5M
254.7M
Weighted Average Shares Outstanding, Diluted
22.3M
308.6M
295.5M
254.7M
Balance sheet
MicroVision, Inc. balance sheet, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Cash and Cash Equivalents
$32.4M
$54.5M
$45.2M
$20.5M
Estimated Fair Value
$42.5M
—
—
—
Restricted Cash, Current
$497.0K
$261.0K
$3.3M
—
Accounts Receivable
$47.0K
$926.0K
$949.0K
—
Inventory
$745.0K
$2.3M
$3.9M
$1.9M
Other Non-Operating Current Assets
$5.0M
$4.3M
$4.9M
$2.3M
Total current assets
$81.1M
$82.5M
$86.8M
$91.0M
Property, Plant and Equipment
$4.3M
$7.1M
—
$6.8M
Operating Lease Right-of-Use Asset
$14.1M
$16.7M
$13.8M
$14.6M
Restricted Cash, Current
$1.2M
$1.5M
$961.0K
$1.4M
Intangible Assets
$32.0K
$11.0M
$17.2M
$75.0K
Other Non-Operating Current Assets
$2.4M
$2.4M
$1.9M
$1.1M
Total assets
$103.1M
$121.2M
$129.6M
$115.0M
Accounts Payable
$1.6M
$1.1M
$2.3M
$2.1M
Other Current Liabilities
$5.4M
$2.5M
$8.6M
$2.1M
Short-Term Debt
$19.2M
$24.2M
—
—
Operating Lease Liability, Current
$3.5M
$2.7M
$2.3M
$1.8M
Short-Term Debt
$14.0K
—
—
$21.0K
Other Non-Operating Current Liabilities
$388.0K
$14.6M
$6.3M
—
Total current liabilities
$30.1M
$46.0M
$20.5M
$11.4M
Warrant liability
$1.9M
—
—
—
Operating Lease Liability, Non-Current
$14.0M
$16.0M
$12.7M
$13.8M
Long-Term Debt
$27.0K
$8.8M
—
$0
Other Non-Operating Non-Current Liabilities
$1.5M
$1.7M
$614.0K
—
Total liabilities
$47.6M
$72.4M
$33.8M
$25.3M
Total Stockholders' Equity
$306.0K
$225.0K
$195.0K
$171.0K
Additional Paid-In Capital
$1.0B
$910.8M
$860.8M
$772.2M
Accumulated Other Comprehensive Income
$669.0K
—
$210.0K
($127.0K)
Retained Earnings
($957.3M)
($862.3M)
($765.4M)
($682.5M)
Total shareholders’ equity
$55.5M
$48.8M
$95.8M
$89.7M
Total liabilities and shareholders’ equity
$103.1M
$121.2M
$129.6M
$115.0M
MicroVision, Inc. balance sheet, quarters
Line item
Jun 30, 2026
Mar 31, 2026
Sep 30, 2025
Jun 30, 2025
Cash and Cash Equivalents
$27.2M
$46.1M
$72.8M
$74.1M
Restricted Cash, Current
$482.0K
$485.0K
$328.0K
$76.0K
Accounts Receivable
$915.0K
$732.0K
$40.0K
$104.0K
Inventory
$3.7M
$4.0M
$8.1M
$6.1M
Other Non-Operating Current Assets
$2.0M
$2.9M
$7.0M
$5.5M
Total current assets
$34.3M
$54.2M
$115.0M
$103.2M
Property, Plant and Equipment
$15.8M
$17.3M
$6.6M
$6.7M
Operating Lease Right-of-Use Asset
$17.7M
$17.9M
$15.4M
$16.1M
Restricted Cash, Non-Current
$1.2M
$1.2M
—
—
Intangible Assets
$13.7M
$13.7M
$10.3M
$10.5M
Goodwill
$3.7M
$3.7M
—
—
Other Non-Operating Current Assets
$2.3M
$2.2M
$2.3M
$2.4M
Total assets
$88.6M
$110.2M
$150.8M
$140.6M
Accounts Payable
$5.9M
$4.5M
$1.3M
$1.6M
Other Current Liabilities
$7.5M
$7.5M
$3.8M
$2.3M
Deferred Revenue, Current
$253.0K
$411.0K
—
—
Other Non-Operating Current Liabilities
$7.0M
$2.0M
$1.9M
$2.9M
Short-Term Debt
$24.6M
$32.1M
$29.0M
$32.3M
Operating Lease Liability, Current
$5.1M
$5.0M
$3.2M
$3.5M
Short-Term Debt
$13.0K
$13.0K
$14.0K
$13.0K
Other Non-Operating Current Liabilities
$43.0K
$99.0K
$672.0K
—
Total current liabilities
$50.4M
$51.8M
$39.9M
$42.8M
Warrant liability
$380.0K
$1.3M
$4.1M
$3.7M
Operating Lease Liability, Non-Current
$15.7M
$16.3M
$14.4M
$15.2M
Long-Term Debt
$17.0K
$21.0K
$31.0K
$30.0K
Other Non-Operating Non-Current Liabilities
$1.4M
$1.3M
$1.7M
$1.7M
Total liabilities
$68.0M
$70.7M
$60.1M
$63.5M
Total Stockholders' Equity
$23.0K
$322.0K
$302.0K
$278.0K
Additional Paid-In Capital
$1.0B
$1.0B
$1.0B
$981.6M
Accumulated Other Comprehensive Income
$737.0K
$559.0K
$651.0K
$518.0K
Retained Earnings
($1.0B)
($982.6M)
($919.5M)
($905.3M)
Total shareholders’ equity
$20.6M
$39.5M
$90.7M
$77.1M
Total liabilities and shareholders’ equity
$88.6M
$110.2M
$150.8M
$140.6M
Cash flow statement
MicroVision, Inc. cash flow statement, fiscal years
Line item
Dec 31, 2025 · FY
Dec 31, 2024 · FY
Dec 31, 2023 · FY
Dec 31, 2022 · FY
Net income
($95.0M)
($96.9M)
($82.8M)
($53.1M)
Depreciation Expense
$5.8M
$6.9M
$7.9M
$2.2M
Unrealized (gain) loss on derivative liability
($5.7M)
$8.9M
—
—
Unrealized gain on warrant liability
($4.4M)
—
—
—
Loss on debt extinguishment
$4.7M
—
—
$0
Impairment of intangible assets
$10.1M
$4.2M
—
—
Other Operating Expense
$1.2M
$405.0K
—
—
Restructuring Expense
$2.2M
—
—
—
Restructuring Expense
$9.9M
$2.0M
$76.0K
$87.0K
Interest Expense
$7.3M
—
—
—
Interest Expense
$11.2M
$4.4M
—
—
Share-based compensation expense
$701.0K
$11.5M
$16.1M
$15.5M
Net accretion of premium on short-term investments
($532.0K)
($951.0K)
($1.3M)
$21.0K
Accounts receivable
$879.0K
$23.0K
($949.0K)
$0
Inventory
($8.3M)
($495.0K)
($892.0K)
($168.0K)
Other current and non-current assets
$1.9M
$85.0K
($2.1M)
($217.0K)
Accounts payable
$496.0K
($1.1M)
$942.0K
($1.7M)
Accrued liabilities
$2.9M
($6.1M)
$6.6M
$888.0K
Contract liabilities and other current liabilities
($399.0K)
($188.0K)
($6.5M)
($293.0K)
Net Cash from Operating Activities
($3.0M)
($2.5M)
($2.5M)
($1.3M)
Other long-term liabilities
($457.0K)
$1.2M
$13.0K
—
Net cash used in operating activities
($58.7M)
($68.5M)
($67.1M)
($38.0M)
Proceeds from Investments
$30.1M
$35.4M
$76.7M
$60.6M
Purchases of investment securities
($51.9M)
($26.1M)
($41.7M)
($90.2M)
Advance to Scantinel
($2.2M)
—
—
—
Purchases of property and equipment
($679.0K)
($374.0K)
($1.9M)
($4.4M)
Net cash provided by (used in) investing activities
($24.6M)
$2.7M
$21.8M
($38.1M)
Principal payments under finance leases
($13.0K)
—
($21.0K)
($26.0K)
Principal payments under notes payable
($16.5M)
—
—
—
Proceeds from Stock Issuance
$8.0K
$62.0K
$175.0K
$726.0K
Stock Repurchases (Issuances)
$77.4M
$34.7M
$72.3M
$14.0M
Net cash provided by financing activities
$60.9M
$72.9M
$72.4M
$14.3M
Effect of Exchange Rate on Cash
$316.0K
($166.0K)
$267.0K
—
Change in cash, cash equivalents, and restricted cash
($22.2M)
$6.9M
$27.4M
($61.8M)
Cash, cash equivalents, and restricted cash at beginning of period
$56.2M
$49.4M
$22.0M
$83.7M
Cash, cash equivalents, and restricted cash at end of period
$34.1M
$56.2M
$49.4M
$22.0M
Common stock issued in conversion of note payable
$22.0M
$3.7M
—
—
Issuance of warrants
$6.3M
—
—
—
Acquisition of right-of-use asset
$137.0K
$5.4M
—
—
Foreign currency translation adjustments
$671.0K
($210.0K)
—
—
Unrealized (loss) gain on investment securities, available-for-sale
($2.0K)
—
$153.0K
—
MicroVision, Inc. cash flow statement, quarters
Line item
Jun 30, 2026 · YTD
Mar 31, 2026 · Q1
Sep 30, 2025 · YTD
Jun 30, 2025 · YTD
Net Income
($62.2M)
($25.3M)
($57.2M)
($43.0M)
Depreciation Expense
$5.3M
$2.4M
$4.3M
$3.0M
Unrealized (gain) loss on derivative liability
$4.7M
($3.4M)
($3.9M)
($2.8M)
Unrealized gain on warrant liability
($1.5M)
($604.0K)
($2.2M)
($2.6M)
Loss on debt extinguishment
$3.1M
$3.1M
$4.7M
$4.7M
Bargain purchase gain
($147.0K)
($147.0K)
—
—
Gain on disposal of fixed assets
($168.0K)
($108.0K)
—
—
Other Operating Expense
$9.0K
$9.0K
—
—
Restructuring Expense
$52.0K
$27.0K
—
—
Interest Expense
$8.2M
$2.7M
$7.3M
$7.3M
Share-based compensation expense
$2.3M
$983.0K
$2.2M
$3.9M
Net accretion of premium on short-term investments
($81.0K)
($81.0K)
($284.0K)
($195.0K)
Accounts receivable
($868.0K)
($685.0K)
$886.0K
$822.0K
Inventory
$833.0K
$490.0K
($5.8M)
($3.8M)
Other current and non-current assets
$1.1M
$308.0K
($2.2M)
($210.0K)
Accounts payable
$4.2M
$2.8M
$207.0K
$432.0K
Accrued liabilities
$2.1M
$2.1M
$1.1M
($275.0K)
Contract liabilities and other current liabilities
($92.0K)
$122.0K
$32.0K
($450.0K)
Net Cash from Operating Activities
($2.4M)
($1.1M)
($2.2M)
($1.1M)
Other long-term liabilities
($21.0K)
($107.0K)
($260.0K)
($197.0K)
Net cash used in operating activities
($35.6M)
($16.4M)
($43.3M)
($26.8M)
Proceeds from Investments
$42.5M
$42.5M
$26.7M
$22.4M
Purchases of property and equipment
($448.0K)
($143.0K)
($435.0K)
($307.0K)
Cash paid for business combination
($33.2M)
($33.2M)
—
—
Net cash provided by investing activities
$8.9M
$9.2M
($6.6M)
$2.8M
Principal payments under finance leases
($8.0K)
($3.0K)
($10.0K)
($6.0K)
Net Cash from Financing Activities
$20.6M
$20.7M
—
—
Stock Repurchases (Issuances)
$769.0K
$311.0K
$73.3M
$43.3M
Net cash provided by financing activities
$21.4M
$21.0M
$67.8M
$43.3M
Effect of Exchange Rate on Cash
$111.0K
($74.0K)
$469.0K
$319.0K
Change in cash, cash equivalents, and restricted cash
($5.2M)
$13.7M
$18.3M
$19.5M
Cash, cash equivalents, and restricted cash at beginning of period
$34.1M
$34.1M
$56.2M
$56.2M
Cash, cash equivalents, and restricted cash at end of period
$28.9M
$47.8M
$74.5M
$75.8M
Common stock issued in conversions of notes payable
$24.2M
$8.1M
$22.0M
$22.0M
Acquisition of right-of-use asset
$5.5M
$4.7M
$139.0K
$67.0K
Foreign currency translation adjustment
$92.0K
($86.0K)
$665.0K
$540.0K
Unrealized loss on investment securities, available-for-sale